HER2 Negative S2007
Study #S2007A Phase II Trial of Sacituzumab Govitecan for Patients with HER2-Negative Breast Cancer and Brain Metastases
Back To Clinical Trials NCI Database EntryA Phase II Trial of Sacituzumab Govitecan for Patients with HER2-Negative Breast Cancer and Brain Metastases
Back To Clinical Trials NCI Database Entry